aspirin resistance
Conditions
Interventions
Control group:Basic treatment
Sponsors
Xi'an Hospital of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
No minimum to 65 Years
Inclusion criteria
Inclusion criteria: 1.Agree to participate in this clinical trial and sign the informed consent; 2.Aged < 65 years, gender unlimited, taking single antiplatelet drug; 3.Essen Stroke Risk Scale score <= 3 points; 4.The traditional Chinese medicine with the effect of promoting blood circulation and removing blood stasis should not be used overlapped in the observation period.
Exclusion criteria
Exclusion criteria: 1.Patients with transient ischemic attack and cerebral infarction requiring double antibody; 2.Patients with cerebral hemorrhage after cerebral infarction, cerebral arteritis, brain tumor, brain trauma, cerebral parasitic disease, rheumatic heart disease; 3.Patients with bleeding tendency or severe bleeding within 3 months; 4.Severe hepatic and renal hematopoiesis and metabolic system diseases; 5.Legal disabled patients (blind, deaf, dumb, intellectual, mental and other physical disabilities caused by other reasons), affecting the evaluation of neurological function defects; 6.Suspected or present a history of alcohol and drug abuse, or other conditions that, in the investigator's judgment, reduce or complicate the likelihood of inclusion; 7.Participating in other clinical trials or participating in clinical trials of other drugs for less than 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Platelet aggregation rate;Toll-like receptor 4;ranscription factor;Myeloid differentiation factor 88;Thromboxane B2; | — |
Secondary
| Measure | Time frame |
|---|---|
| Cyclooxygenase-2;Interleukin-6;Thromboxane B2;C-reactive protein; | — |
Countries
China
Contacts
Public ContactWang Hui
Xi'an Hospital of Traditional Chinese Medicine
Outcome results
None listed